Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Wellesley Hills, Massachusetts
- Most recent report
- 10-Q, filed Nov 5, 2026
- Incorporated
- Delaware
- Filings on record
- 326 filings
- On EDGAR
- CIK 1768446
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
Financials 8 of 23
News 8 of 66
Prospectuses and Registrations 8 of 21
- S-3ASR Automatic shelf registration Nov 5, 2026
- 424B5 Prospectus supplement for an offering Jun 12, 2026
- 424B3 Prospectus supplement for an offering Jun 9, 2026
- S-3 Shelf registration statement May 29, 2026
- S-8 Registration statement for an employee plan Mar 5, 2026
- S-8 Registration statement for an employee plan Apr 1, 2025
- 424B5 Prospectus supplement for an offering Mar 25, 2025
- S-3 Shelf registration statement Nov 12, 2024
Proxies 8 of 15
- DEFA14A Extra proxy material Apr 24, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2026
- PRE 14A Preliminary proxy statement Apr 10, 2026
- DEFA14A Extra proxy material May 23, 2025
- DEFA14A Extra proxy material Apr 25, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2025
- DEFA14A Extra proxy material Jun 14, 2024
- DEFA14A Extra proxy material Jun 12, 2024
Ownership 8 of 161
- SCHEDULE 13D/A Large holder reported an active stake, amended Nov 9, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Nov 5, 2026
- SCHEDULE 13G Large holder reported a passive stake Oct 28, 2026
- SCHEDULE 13G Large holder reported a passive stake Oct 27, 2026
- 4 Insider reported a trade Sep 30, 2026
- 4 Insider reported a trade Sep 17, 2026
- 144 Notice of a proposed sale of restricted stock Sep 15, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
Other 8 of 40
- EFFECT Notice that a registration became effective Jun 9, 2026
- CORRESP Reply to SEC staff Jun 5, 2026
- UPLOAD Comment letter from SEC staff Jun 4, 2026
- D May 4, 2026
- ARS Annual report sent to shareholders Apr 24, 2026
- ARS Annual report sent to shareholders Apr 25, 2025
- EFFECT Notice that a registration became effective Nov 22, 2024
- CORRESP Reply to SEC staff Nov 20, 2024
Everything here comes from Climb Bio, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.